Literature DB >> 28207930

Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII.

Francyne Kubaski1,2,3, Ana Carolina Brusius-Facchin4, Robert W Mason1,2, Pravin Patel5, Maira G Burin4, Kristiane Michelin-Tirelli4, Rejane Gus Kessler4, Fernanda Bender4, Sandra Leistner-Segal4,6, Carolina A Moreno7, Denise P Cavalcanti7, Roberto Giugliani3,4,6,8, Shunji Tomatsu1,2.   

Abstract

OBJECTIVE: The aim of this study was to quantify glycosaminoglycans (GAGs) in amniotic fluid (AF) from an MPS VII fetus compared with age-matched fetuses obtained from normal pregnancies.
METHOD: Disaccharides were measured by liquid chromatography tandem mass spectrometry, compared to age-matched controls. Enzyme assay was performed in AF supernatant or cultured amniocytes. GUSB was analyzed by next generation sequencing using Ion Torrent Personal Genome Machine with a customized panel.
RESULTS: No activity of β-glucuronidase was detected in fetal cells. The pregnancy was spontaneously terminated in the third trimester. Genetic studies identified a homozygous mutation of p.N379D (c.1135A > G) in the GUSB gene. Liquid chromatography tandem mass spectrometry showed that chondroitin sulfate, dermatan sulfate, heparan sulfate, and keratan sulfate levels were markedly increased in the MPS VII AF, compared to those in age-matched control AF (dermatan sulfate, heparan sulfate, and chondroitin-6-sulfate more than 10 × than age-matched controls; chondroitin-4-sulfate and keratan sulfate more than 3 times higher).
CONCLUSION: This is the first report of specific GAG analysis in AF from an MPS VII fetus, indicating that GAG elevation in AF occurs by 21 weeks of gestation and could be an additional tool for prenatal diagnosis of MPS VII and potentially other MPS types.
© 2017 John Wiley & Sons, Ltd. © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28207930      PMCID: PMC5436936          DOI: 10.1002/pd.5028

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  60 in total

1.  Cloning and characterization of the human beta-glucuronidase gene.

Authors:  R D Miller; J W Hoffmann; P P Powell; J W Kyle; J M Shipley; D R Bachinsky; W S Sly
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

2.  Cloning, sequencing, and expression of cDNA for human beta-glucuronidase.

Authors:  A Oshima; J W Kyle; R D Miller; J W Hoffmann; P P Powell; J H Grubb; W S Sly; M Tropak; K S Guise; R A Gravel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  Placenta analysis of prenatally diagnosed patients reveals early GAG storage in mucopolysaccharidoses II and VI.

Authors:  Guilherme Baldo; Ursula Matte; Osvaldo Artigalas; Ida Vanessa Schwartz; Maira Graeff Burin; Erlane Ribeiro; Dafne Horovitz; Tatiana Pacheco Magalhaes; Milan Elleder; Roberto Giugliani
Journal:  Mol Genet Metab       Date:  2011-03-22       Impact factor: 4.797

4.  Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation.

Authors:  Y Yamada; K Kato; K Sukegawa; S Tomatsu; S Fukuda; S Emura; S Kojima; T Matsuyama; W S Sly; N Kondo; T Orii
Journal:  Bone Marrow Transplant       Date:  1998-03       Impact factor: 5.483

5.  Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes.

Authors:  J M Shipley; M Klinkenberg; B M Wu; D R Bachinsky; J H Grubb; W S Sly
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

6.  Fetal presentation of Morquio disease type A.

Authors:  M Beck; S Braun; W Coerdt; E Merz; E Young; A C Sewell
Journal:  Prenat Diagn       Date:  1992-12       Impact factor: 3.050

7.  Mucopolysaccharidosis type VII (beta-glucuronidase deficiency): a chronic variant with an oligosymptomatic severe skeletal dysplasia.

Authors:  R D de Kremer; I Givogri; C E Argaraña; E Hliba; R Conci; C D Boldini; A P Capra
Journal:  Am J Med Genet       Date:  1992-09-15

8.  Beta-glucuronidase deficiency in a girl with unusual clinical features.

Authors:  R A Pfeiffer; H Kresse; N Bäumer; E Sattinger
Journal:  Eur J Pediatr       Date:  1977-10-12       Impact factor: 3.183

9.  Molecular analysis of a patient with hydrops fetalis caused by beta-glucuronidase deficiency, and evidence for additional pseudogenes.

Authors:  R Vervoort; W Lissens; I Liebaers
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

10.  Four novel mutations in mucopolysaccharidosis type VII including a unique base substitution in exon 10 of the beta-glucuronidase gene that creates a novel 5'-splice site.

Authors:  S Yamada; S Tomatsu; W S Sly; R Islam; D A Wenger; S Fukuda; K Sukegawa; T Orii
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

View more
  8 in total

Review 1.  Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future.

Authors:  Hui Hsuan Chen; Kazuki Sawamoto; Robert W Mason; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Shunji Tomatsu
Journal:  J Hum Genet       Date:  2019-08-27       Impact factor: 3.172

2.  Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans.

Authors:  Nivethitha Arunkumar; Dung Chi Vu; Shaukat Khan; Hironori Kobayashi; Thi Bich Ngoc Can; Tsubasa Oguni; Jun Watanabe; Misa Tanaka; Seiji Yamaguchi; Takeshi Taketani; Yasuhiko Ago; Hidenori Ohnishi; Sampurna Saikia; José V Álvarez; Shunji Tomatsu
Journal:  Diagnostics (Basel)       Date:  2021-07-27

Review 3.  Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.

Authors:  Monique Piraud; Magali Pettazzoni; Pamela Lavoie; Séverine Ruet; Cécile Pagan; David Cheillan; Philippe Latour; Christine Vianey-Saban; Christiane Auray-Blais; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2018-03-19       Impact factor: 4.982

Review 4.  Advances in glycosaminoglycan detection.

Authors:  Shaukat A Khan; Robert W Mason; Hironori Kobayashi; Seiji Yamaguchi; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2020-03-27       Impact factor: 4.797

Review 5.  Epidemiology of Mucopolysaccharidoses Update.

Authors:  Betul Çelik; Saori C Tomatsu; Shunji Tomatsu; Shaukat A Khan
Journal:  Diagnostics (Basel)       Date:  2021-02-10

6.  THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes.

Authors:  Dhananjay Yellajoshyula; Samuel S Pappas; Abigail E Rogers; Biswa Choudhury; Xylena Reed; Jinhui Ding; Mark R Cookson; Vikram G Shakkottai; Roman J Giger; William T Dauer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

Review 7.  Diagnosis of Mucopolysaccharidoses.

Authors:  Francyne Kubaski; Fabiano de Oliveira Poswar; Kristiane Michelin-Tirelli; Maira Graeff Burin; Diana Rojas-Málaga; Ana Carolina Brusius-Facchin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Diagnostics (Basel)       Date:  2020-03-22

8.  Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.

Authors:  Tsubasa Oguni; Shunji Tomatsu; Misa Tanaka; Kenji Orii; Toshiyuki Fukao; Jun Watanabe; Seiji Fukuda; Yoshitomo Notsu; Dung Chi Vu; Thi Bich Ngoc Can; Atsushi Nagai; Seiji Yamaguchi; Takeshi Taketani; Michael H Gelb; Hironori Kobayashi
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.